Recruiting OBSERVATIONAL NCT05656261

APOL1 Genetic Testing in African Americans

APOL1 Genetic Testing in African Americans: Exploring Attitudes About Genetic Risk to Improve Comprehensive Kidney Risk Assessment for Patients and Families

Sponsor: Mid-America Transplant

Conditions APOL1 Associated Kidney Disease Chronic Kidney Diseases Disparities Genetic Predisposition Nephropathy

Interventions Assessment of the frequency of APOL-1 renal risk variant in the black population, and evaluating their attitudes about genetic testing and APOL1 genotype via self-administered surveys

Updated 7 times since 2023 Last updated: Mar 17, 2025 Started: Jan 24, 2019 Primary completion: Jun 30, 2026 Completion: Jun 30, 2027

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

A observational or N/A phase clinical study on APOL1 Associated Kidney Disease and Chronic Kidney Diseases, this trial is actively recruiting participants. The trial is conducted by Mid-America Transplant and has accumulated 7 data snapshots since 2019. Longitudinal tracking of this trial contributes to a broader understanding of treatment development timelines.

Status Flow

Change History

7 versions recorded

Sep 2025 — Present [monthly]

Recruiting
Apr 2025 — Sep 2025 [monthly]

Recruiting
Sep 2024 — Apr 2025 [monthly]

Recruiting
Jul 2024 — Sep 2024 [monthly]

Recruiting
Apr 2024 — Jul 2024 [monthly]

Recruiting

▶ Show 2 earlier versions

Apr 2023 — Apr 2024 [monthly]

Recruiting
Jan 2023 — Apr 2023 [monthly]

Recruiting

First recorded

Jan 2019

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Mid-America Transplant
St. Louis University

Data source: St. Louis University

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• St Louis, United States